Skip to Main Content.
Site navigation
Fidelity.com Home
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log In
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log Out
  • Accounts & Trade
    • Portfolio Log In Required
    • Portfolio
    • AccountPositions Log In Required
    • AccountPositions
    • Trade Log In Required
    • Trade
    • Trading Dashboard Log In Required
    • Trading Dashboard Log In Required
    • Active Trader Pro
    • Transfers
    • Cash Management Log In Required
    • Cash Management
    • Bill Pay Log In Required
    • Bill Pay
    • Full View Log In Required
    • Full View
    • Security Settings Log In Required
    • Security Settings
    • Account Features Log In Required
    • Account Features
    • Statements Log In Required
    • Statements
    • Fidelity Alternative Investments Program Log In Required
    • Tax Forms & Information
    • Retirement Distributions Log In Required
    • Fidelity Rewards+registered trademark Log In Required
    • Fidelity Rewards+registered trademark Log In Required
    • New Account Checklist Log In Required
    • Lending Solutions-Line of Credit Log In Required
    • Refer a Friend
  • Planning & Advice
    • What We Offer
    • Build Your Plan
    • My Goals
    • Financial Basics
    • Building Savings
    • Robo Investing Plus Financial Advice
    • Wealth Management
    • Find an advisor
    • Retirement
    • Life Events
    • Saving & Investing for a Child
    • Charitable Giving
  • News & Research
    • News
    • Wealth Management Insights
    • Watch List Log In Required
    • Quotes
    • Quotes
    • Alerts Log In Required
    • Mutual Funds
    • Stocks
    • Fixed Income, Bonds & CDs
    • ETFs
    • Options
    • Markets & Sectors
    • IPOs
    • Annuities
    • Learning Center
    • Notebook
    • Notebook
  • Investment Products
    • Mutual Funds
    • Retirement & IRAs
    • Stocks and Trading
    • Crypto
    • Direct Indexing
    • Fixed Income, Bonds & CDs
    • ETFs
    • Options
    • Sustainable Investing
    • Cash Management & Credit Cards
    • Managed Accounts
    • 529 College Savings
    • Health Savings Accounts
    • Annuities
    • Life Insurance & Long Term Care
  • Why Fidelity
    • The Fidelity Advantage
    • Planning & Advice
    • Trading
    • Straightforward Pricing
    • Insights & Tools
    • Security & Protection
    • Marketplace Solutions
    • About Fidelity
    • Careers
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log In
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log Out
Content and data provided by various third parties and Fidelity − Terms of Use
  • Research >
  • Stocks >
  • News & Events >

Stock Details


  • Snapshot
  • Detailed Quote
  • Advanced Chart &
    Technical Analysis Opens in New Window
  • News & Events
  • Compare
  • Analyst Opinions
  • Research Reports
  • Key Statistics
  • Earnings
  • Dividends
  • Ownership & Insiders
  • Financial Statements
  • SEC Filings

RELATED RESOURCES

  • Stock Research Overview
  • Stock Screeners
  • Markets & Sectors
  • Fidelity Learning Center Opens in New Window
Print Format
Change Text Size:
  • Default text sizeA
  • Larger text sizeA
  • Largest text sizeA

77 Stocks Moving In Tuesday's Mid-Day Session

BY Benzinga
— 12:00 PM ET 05/10/2022

Gainers

  • Biohaven Pharmaceutical Holding Company Ltd. NASDAQ:BHVN shares jumped 70.8% to $142.01. Pfizer Inc NYSE:PFE will acquire Biohaven Pharmaceutical Holding for $148.50 per share, equivalent to $11.6 billion.
  • Vroom, Inc. NASDAQ:VRM shares gained 38.4% to $1.4950 after the company reported better-than-expected Q1 results.
  • Appian Corporation NASDAQ:APPN gained 34.5% to $57.86. Appian was awarded $2.036 billion in damages against Pegasystems Inc..
  • AdaptHealth Corp. NASDAQ:AHCO shares climbed 25.9% to $14.39 after the company reported upbeat Q1 sales and announced a $200 million buyback.
  • CECO Environmental Corp. NASDAQ:CECE gained 24.7% to $5.30 after the company posted upbeat Q1 results and announced the purchase of Compass Water Solutions.
  • Assertio Holdings, Inc. NASDAQ:ASRT rose 23.1% to $2.3150 after the company reported better-than-expected Q1 EPS and sales results.
  • Aurinia Pharmaceuticals Inc. NASDAQ:AUPH gained 22.2% to $10.93 following strong quarterly sales.
  • ShockWave Medical, Inc. NASDAQ:SWAV jumped 21.1% to $140.38 after the company reported better-than-expected Q1 results and raised its FY22 sales guidance to above analyst estimates.
  • FibroGen, Inc. NASDAQ:FGEN gained 20.2% to $9.55 after the company reported better-than-expected Q1 EPS results.
  • The Pennant Group, Inc. NASDAQ:PNTG jumped 19.7% to $15.32 following strong quarterly results.
  • Myovant Sciences Ltd. NYSE:MYOV gained 19% to $9.26 following Q4 earnings.
  • Intra-Cellular Therapies, Inc. NASDAQ:ITCI gained 18.6% to $50.97 after reporting narrower-than-expected quarterly loss.
  • Angi Inc. NASDAQ:ANGI jumped 18% to $4.2350 following upbeat quarterly sales.
  • Cyngn Inc. NASDAQ:CYN gained 17.8% to $5.01.
  • Cara Therapeutics, Inc. NASDAQ:CARA gained 17.7% to $8.77 after reporting upbeat quarterly results.
  • Y-mAbs Therapeutics, Inc. NASDAQ:YMAB jumped 16.8% to $9.61 following narrower-than-expected quarterly loss.
  • Park-Ohio Holdings Corp. NASDAQ:PKOH gained 16.6% to $11.50 after the company reported better-than-expected Q1 sales results and EPS results were higher year over year.
  • Haemonetics Corporation NYSE:HAE gained 16.5% to $57.41 following better-than-expected quarterly results.
  • Nuvation Bio Inc. NYSE:NUVB jumped 16.1% to $4.91 after the company posted a narrower quarterly loss.
  • Cronos Group Inc. NASDAQ:CRON rose 14.4% to $3.24 following Q1 results.
  • Cortexyme, Inc. NASDAQ:CRTX gained 14% to $3.74. Cortexyme agreed to acquire privately held Novosteo, which is focused on targeted therapeutics to treat rare skeletal diseases, bone cancer and injury.
  • Coupang, Inc. NYSE:CPNG jumped 13.3% to $10.60.
  • OPKO Health, Inc. NASDAQ:OPK jumped 12.7% to $2.75 following Q1 results.
  • Seagen Inc. NASDAQ:SGEN gained 12.2% to $122.25. The Board of Directors of Seagen announced that its long-time president, CEO, and chairman Clay Siegall, is on a leave of absence.
  • Color Star Technology Co., Ltd. NASDAQ:CSCW rose 12.1% to $0.1278 after dropping 12% on Monday.
  • Nutex Health, Inc. NASDAQ:NUTX rose 11.4% to $5.18 after declining 22% on Monday.
  • LivePerson, Inc. NASDAQ:LPSN rose 10.9% to $18.08 following Q1 results.
  • NeuroBo Pharmaceuticals, Inc. NASDAQ:NRBO rose 9.5% to $0.5113 after tumbling 23% on Monday.
  • Evolve Transition Infrastructure LP NYSE:SNMP rose 7.8% to $0.4398 after declining around 7% on Monday.
  • Cenntro Electric Group Limited NASDAQ:CENN rose 7.1% to $1.5850. Nuvve Holding Corp. and Cenntro reported an alliance to accelerate adoption of commercial electric vehicles.
  • Clover Health Investments, Corp. NASDAQ:CLOV rose 5.4% to $2.54 after the company reported better-than-expected Q1 sales results and reaffirmed its FY22 guidance.

 

Losers

  • Upstart Holdings, Inc. NASDAQ:UPST shares dipped 56.7% to $33.38 after the company reported Q1 earnings results and issued Q2 and FY22 sales guidance below analyst estimates.
  • Kaleyra, Inc. NYSE:KLR dipped 38.8% to $3.7250 after the company reported worse-than-expected Q1 EPS and sales results and issued Q2 and FY22 sales guidance below analyst estimates.
  • United Insurance Holdings Corp. NASDAQ:UIHC fell 38.5% to $1.3770 after the company reported a wider Q1 core loss.
  • Embark Technology, Inc. NASDAQ:EMBK dropped 37.8% to $2.1696.
  • Cipher Mining Inc. NASDAQ:CIFR fell 36.2% to $2.06. Cipher Mining posted a Q1 loss of $0.07 per share.
  • Desktop Metal, Inc. NYSE:DM dropped 35.3% to $2.2101 following wider-than-expected quarterly loss.
  • Akanda Corp. NASDAQ:AKAN dipped 28% to $1.6291.
  • FutureFuel Corp. NYSE:FF fell 28.7% to $7.04 after the company said Q1 EPS results were lower year over year.
  • Diebold Nixdorf, Incorporated NYSE:DBD fell 28% to $2.7350 after the company posted downbeat quarterly results and lowered sales guidance.
  • Enochian Biosciences, Inc. NASDAQ:ENOB fell 27.8% to $4.65.
  • Tenon Medical, Inc. NASDAQ:TNON fell 26.8% to $36.42.
  • Bausch Health Companies Inc. NYSE:BHC fell 26.4% to $9.49 after the company reported Q1 sales results were down year over year and cut FY22 guidance.
  • Huadi International Group Co., Ltd. NASDAQ:HUDI dipped 26.4% to $21.20.
  • GoodRx Holdings, Inc. NASDAQ:GDRX shares fell 25.7% to $7.99 after the company Q1 earnings results and issued Q2 sales guidance below analyst estimates.
  • National Vision Holdings, Inc. NASDAQ:EYE dropped 25.4% to $25.04 as the company lowered FY22 guidance.
  • FTC Solar, Inc. NASDAQ:FTCI fell 24.9% to $2.4699 following downbeat quarterly results.
  • CarGurus, Inc. NASDAQ:CARG fell 24.4% to $22.56 after the company reported Q1 earnings results and issued Q2 adjusted EPS guidance below analyst estimates.
  • Spark Networks SE NASDAQ:LOV dipped 20.7% to $1.64 following Q1 results.
  • loanDepot, Inc. NYSE:LDI dropped 20.3% to $2.15 as the company swung to a loss in the first quarter.
  • Cvent Holding Corp. NASDAQ:CVT fell 19.6% to $4.3050 following Q1 results.
  • AppFolio, Inc. NASDAQ:APPF dipped 18.8% to $80.99 after reporting a loss for the first quarter.
  • Infrastructure and Energy Alternatives, Inc. NASDAQ:IEA dropped 18.3% to $7.01 following wider-than-expected quarterly loss.
  • LogicBio Therapeutics, Inc. NASDAQ:LOGC fell 17.8% to $0.5487. LogicBio Therapeutics shares jumped over 34% on Monday after the company announced the FDA lifted the clinical hold on its LB-001 Investigational New Drug Application, allowing patient enrollment to resume in the Phase 1/2 SUNRISE trial for pediatric patients with methylmalonic acidemia.
  • StarTek, Inc. NYSE:SRT declined 17.2% to $3.3350 following Q1 results.
  • TaskUs, Inc. NASDAQ:TASK dropped 16.4% to $19.50 following Q1 results.
  • Wejo Group Limited NASDAQ:WEJO declined 16.2% to $2.18.
  • Babcock & Wilcox Enterprises, Inc. NYSE:BW fell 16% to $5.96 following wider-than-expected quarterly loss.
  • FreightCar America, Inc. NASDAQ:RAIL dropped 15.4% to $4.29 after reporting Q1 loss.
  • Village Farms International, Inc. NASDAQ:VFF dipped 15.1% to $3.26 following weak quarterly results.
  • Benson Hill, Inc. NYSE:BHIL fell 14.6% to $2.4550.
  • Local Bounti Corporation NYSE:LOCL declined 14.5% to $4.40 following Q1 results.
  • Lightwave Logic, Inc. NASDAQ:LWLG fell 14.4% to $8.02.
  • Eve Holding Inc. NYSE:EVEX dropped 14.3% to $9.70. Eve Holding reported that its common stock will begin trading on NYSE today under the symbol 'EVEX.'
  • Science 37 Holdings, Inc. NASDAQ:SNCE dropped 14% to $3.19. Science 37 Holdings reported better-than-expected Q1 EPS and sales results.
  • Starry Group Holdings, Inc. NYSE:STRY fell 14% to $7.22.
  • Dave Inc. NASDAQ:DAVE dipped 13.3% to $2.29.
  • Vivid Seats Inc. NASDAQ:SEAT dropped 12.7% to $7.52 following Q1 results.
  • Veeco Instruments Inc. NASDAQ:VECO fell 11.8% to $20.08 after the company issued weak earnings forecast.
  • Matrix Service Company NASDAQ:MTRX dropped 11.6% to $5.74 following wider Q3 loss.
  • TrueCar, Inc. NASDAQ:TRUE fell 11.5% to $3.13. TrueCar posted a Q1 net loss of $12.4 million.
  • Aterian, Inc. NASDAQ:ATER shares fell 11.5% to $3.5301 after the company reported worse-than-expected Q1 sales results.
  • Affirm Holdings, Inc. NASDAQ:AFRM fell 11.4% to $18.25 after Upstart reported financial results and issued guidance below analyst estimates.
  • Revlon, Inc. NYSE:REV fell 11.4% to $4.5093. Revlon recently posted a Q1 loss of $1.14 per share.
  • Groupon, Inc. NASDAQ:GRPN fell 10.6% to $13.99 after the company reported weaker-than-expected results for its first quarter and issued weak FY22 sales guidance.
  • Novavax, Inc. NASDAQ:NVAX fell 9.5% to $48.19 as the company posted downbeat results for its first quarter on Monday.
  • Blue Water Vaccines, Inc. NASDAQ:BWV fell 7.8% to $4.9999 after jumping 44% on Monday.

 

 

 

 

More FGEN News

  • BRIEF-FibroGen Q1 Loss Per Share $0.68
    Reuters - 5:13 PM ET 05/09/2022
  • FibroGen Reports First Quarter 2022 Financial Results
    GlobeNewswire - 4:01 PM ET 05/09/2022
  • The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More
    Benzinga - 8:33 AM ET 05/09/2022
Fidelity Investments. Copyright 1998–2022 FMR LLC. 
All rights reserved. 

  • Terms of Use|
  • Privacy|
  • Security|
  • Site Map 
Close